|
Sherry here. You made a good point. I wrote the first line of code exactly 2 years ago, at that time, we couldn't even find the infrastructure that is hipaa compliant (like messaging api etc), and we have to build everything on our own. We observed the rise of digital health in the last two years, which used to be a niche space. In fact, GoodRx is about to launch a telemedicine marketplace, to address the "hard to choose" issue you mentioned. Healthcare is complicated, I think you would agree with me. It is a highly regulated industry, complicated ecosystem: physician, payers, patients, hospitals etc. To disrupt this industry, one company is not enough, so I actually think popularity of digital health startups is a good thing in general to really push the consumer adoption and the regulation to catch up. In the cancer space, the quality of the services are super important - save lives. One good example is Memorial Sloan Kettering (MSK) - where Lily used to work at. MSK treats cancer only and does it super well. Patients from all over the world will come to treat there. We are the first mover and we want to be the "MSK" in digital space. We are partnering with other parties in the ecosystem, if you are interested, here are more details: https://www.forbes.com/sites/berenicemagistretti/2020/08/05/... We think our direct to consumer channel really helped the patients, as we already served many patients who would not be able to access the care easily. For example, they are in rural areas, or they live in places that do not have good cancer centers, or they are too busy to go to the hospitals, etc. We see the huge needs there. That is also the original drive why we started this company. Regarding the product, we are still iterating the product for sure. Cancer is different from flu. It usually involves survey, chemo, radiation and others. It is quite complicated and the treatment could last 6 months to 1 year. Patients have questions all the time during the long period, that is why we think our chat solution could really add value. Thanks for suggestions on payers side collaboration. |